Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Addex Therapeutics Ltd. Sponsored ADR (ADXN) had Income from Continuous Operations of $-2.37M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.23M |
|
-- |
|
-- |
|
$0.89M |
|
$-0.89M |
|
$-1.50M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
|
Income from Continuous Operations |
$-2.37M |
$-2.23M |
|
$-2.37M |
|
$-0.89M |
|
$-0.89M |
|
0.84M |
|
0.84M |
|
$-2.91 |
|
$-2.91 |
|
| Balance Sheet Financials | |
$3.22M |
|
$0.00M |
|
$7.09M |
|
$10.31M |
|
$1.39M |
|
-- |
|
$0.17M |
|
$1.57M |
|
$8.74M |
|
$8.74M |
|
$8.74M |
|
0.93M |
|
| Cash Flow Statement Financials | |
$-1.23M |
|
$-0.89M |
|
$0.91M |
|
$4.05M |
|
$2.79M |
|
$-1.26M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.23M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.16% |
|
-27.16% |
|
-23.03% |
|
-27.16% |
|
$9.43 |
|
$-1.47 |
|
$-1.47 |
|